findmyKOL
Clinical trialNCT05873439CompletedEarly phase 1Interventional

Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC

SponsorH. Lee Moffitt Cancer Center and Research InstituteEnrollment3Nonsmall Cell Lung CancerNonsmall Cell Lung Cancer Stage IIINonsmall Cell Lung Cancer, Stage IIUnresectable Non-Small Cell Lung Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Moffitt Cancer Center

    Tampa, Florida, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
25 May 2023
Primary completion
29 Nov 2023
Completion
21 Aug 2024
Last update posted
1 Apr 2026
Registered enrollment
3
Registry id
NCT05873439
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.